Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
Lauren P WallnerMousumi BanerjeeDavid Reyes-GastelumAnn S HamiltonKevin C WardCarrie LubitzSarah T HawleyMegan R HaymartPublished in: The Journal of clinical endocrinology and metabolism (2021)
Physician perspectives and attitudes about using RAI, as well as patient volume, influence RAI use for low-risk thyroid cancer. Efforts to reduce overuse of RAI in low-risk thyroid cancer should include interventions targeted toward physicians, in addition to patients.